We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




The Financial Impact of Traffic-Related Asthma Underestimated

By HospiMedica International staff writers
Posted on 23 Feb 2012
A new study suggests that the impact of traffic on preexisting asthma represents only half of the attributable costs, with the other half coming from new asthma cases caused by traffic-related pollution (TRP).

Researchers at the University of Massachusetts (Amherst, USA), the University of Basel (Switzerland), and other institutions evaluated the costs of childhood asthma due to traffic-related pollution in two California (USA) communities, Riverside and Long Beach, where traffic is the main culprit in poor air quality and heavily used roads are close to residential neighborhoods. More...
The researchers looked at two main outcomes: bronchitic episodes and the cost of care for a child with asthma, with about 30% of the annual cost of an asthma case stemming from school absences, and 25% from sinus and ear infections and other related conditions.

The results showed that the typical asthma case costs about USD 4,000 a year, representing 7%-8% of the median household income. The TRP-attributable direct and indirect costs related to asthma in Riverside corresponded to 6% of the county's total budget for health and welfare, and in Long Beach represented 21% of the city's health and human services expenditures. When compared with other communities with similar background air-pollution levels, the authors estimated that Riverside and Long Beach together bore an additional USD 18 million in total annual direct and indirect costs from TRP asthma cases and exacerbations. The study was published early online on January 20, 2012, in the European Respiratory Journal.

“These results are troublesome because the sustainable healthcare expenditure of an entire family is considered to be 5% of income,” concluded lead author Sylvia Brandt, PhD, and colleagues. “The fact that together these two communities account for only 7% of the population of California suggests that the state-wide costs are truly substantial.”

Related Links:

University of Massachusetts
University of Basel




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.